GlassScriptPhysician profile
Brian D Kittelson
NPI 1730234345
$16,427.35
in general payments reported to CMS, 2019-2025
11 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $2,712 · 2023: $5,144 · 2024: $7,971 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,328 · Travel and Lodging: $2,465 · Food and Beverage: $2,318 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,328.00 |
| Travel and Lodging | $2,465.30 |
| Food and Beverage | $2,317.76 |
| Education | $197.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $12,611.43 | 2021-2025 | |
| Inspire Medical Systems, INC. | $2,168.08 | 2022 | |
| Harmony Biosciences LLC | $734.01 | 2021-2025 | Wakix |
| Axsome Therapeutics, INC. | $338.20 | 2023-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $185.61 | 2023-2025 | Lumryz |
| Idorsia Pharmaceuticals US INC | $182.59 | 2023 | Quviviq |
| Zoll Respicardia, INC. | $94.93 | 2024 | Remede System |
| Merck Sharp & Dohme LLC | $37.46 | 2021-2022 | |
| Eisai INC. | $30.42 | 2021 | |
| Itamar Medical INC | $30.09 | 2024 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kittelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.